Global Acute Kidney Injury Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global Acute Kidney Injury Treatment Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global acute kidney injury treatment market report has been segmented on the basis of injury type, therapy type, distribution channel, and region.
Global Acute Kidney Injury Treatment Market: Overview
Acute kidney injury (ADK) is characterized by a sudden loss in kidney function, characterized increasing serum creatinine level without loss urine. These injuries are causes due to building of waste products in the blood. Acute kidney injury affected other organs of body such as the heart, lungs, and brain. Acute kidney injury is most common in patients admitted at hospital, intensive care units (ICU), among older adults. According to the World Health Organization (WHO), the overall prevalence of Chronic kidney disease (CKD) in the general population is approximately 14 percent
Global Acute Kidney Injury Treatment Market: Dynamics
Increasing number of cases of renal failure and rising prevalence of lifestyle-related diseases such as diabetes and obesity are the major factors anticipated to drive growth in terms of revenue of the target market over the forecast years. Additionally, rising health expenditure among the population, growing aging population, technological advancement in the medical sector, increasing government initiatives for management of chronic kidney diseases are some of the additional factors projected to drive revenue growth of target market. However, stringent rules by various health authority for product approvals and low awareness regarding treatment in underdevloping and developing countries are some factors that could hamper growth rate of the global acute kidney injury treatment market.
Global Acute Kidney Injury Treatment Market: Segment Analysis
Among the distribution channel segments, the hospital pharmacy is expected to contribute highest market share during the forecast years. In addition, online store segment is anticipated to account for fastest growth rate owing to delivery of medicines at the doorsteps directly of customer.
Global Acute Kidney Injury Treatment Market: Trends
The trend observed in the global acute kidney injury treatments market are new product launch, collaboration, merger, and acquisition by key market players. In addition, prominent players in the target market are widening their product portfolio for increasing its revenue share and geographical presence. The government agency along with private players such as the National Kidney Foundation, the FDA, and the European Medicines Agency are conducting new clinical trials activities and developing new treatments medicines for kidney disease. The aforementioned are current trends witnessed in the global acute kidney injury treatment market.
Global Acute Kidney Injury Treatment Market: Regional Analysis
The markets in North America is anticipated to register highest revenue in the target market over the next 10 years. This is primarily due to, increasing number of drug research activities and availability of drugs for treatment of acute kidney injury in countries in the region. The market in the Asia Pacific is anticipated to contributes fastest CAGR. This is owing to, increasing instance of kidney disorders, growing elderly population, and higher investment for better healthcare facilities in countries in the region.
Global Acute Kidney Injury Treatment Market Segmentation:
Segmentation by injury type:
- Intrinsic renal
Segmentation by therapy type:
- Intermittent hemodialysis
- Continuous renal replacement therapy
- Sustained low-efficiency dialysis
Segmentation by distribution channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2019 Estimated Year 2020 Forecast Period 2020–2029 Revenue in US$
- Novartis AG
- Pfizer Inc.
- Ipsen SA
- Merck & Co., Inc.
- Celegene Corp.
- Conatus Pharmaceuticals Inc.
- Valeant Pharmaceuticals International Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan Pharmaceuticals Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!